Precision

guided by strategy

1798 is a healthcare consulting firm with expertise in developing market access strategies, unearthing insights, and establishing value propositions that are meaningful to key stakeholders to deliver a competitive advantage to life science companies.

We are excited to be a part of
ABOUT

Our approach is time-tested

1798 provides a range of health consulting services to biopharmaceutical, medical device, and diagnostic companies. From devising strategies for early-stage research and development to overcoming challenges that occur post-launch in the commercialization process, our customized approach is designed to deliver actionable insights.

OUR 5 GUIDING PRINCIPLES
WE'RE ALL IN THIS TOGETHER

Our senior leadership has vast experience in the industry and is involved from day 1, so they understand all aspects of the business and the unique challenges each client faces.

COMPLIANCE IS NOT AN AFTERTHOUGHT

All analysis and materials strictly reflect the policies and regulations developed by agencies such as CMS, OIG, and the FDA.

NO EXCEPTIONS

RIGOROUS analytics, financial modeling, and market research are the norm.

BEYOND SHARE OF VOICE

Strategies that drive patient and product access with economic stakeholders inform our creative and tactical output.

EVERY CLIENT IS UNIQUE

Each client has a dedicated team and benefits from tools, market access and launch strategies, and field-based solutions that are customized for their exclusive needs.

WHAT’S IN A NUMBER?
0
The year the modern health insurance system was created and our namesake
0
The percentage of clients who request additional work beyond the initial project
0
Our senior team's combined years of experience in the healthcare industry
SERVICES

Full-service to the nth degree

From kickoff to launch and for each phase in between, 1798 provides our clients with the support and expertise they need to bring their projects to fruition.

Market access consulting
Our experts will help your brand optimize market access opportunities.

Our commercialization and access support services help brands overcome market access challenges and capitalize on unique opportunities. Clients benefit from insights, strategies, tactics, and tools to ensure rapid product uptake.

TEAM
Our team comprises industry professionals who collaborate with our clients to deliver cross-functional insights and solutions that result in commercially impactful, cost-effective strategies.
Roshawn Blunt
Managing Director
Roshawn Blunt began her pharmaceutical career at The Boston Consulting Group before transitioning out of consulting and into positions on the manufacturer and provider sides. Roshawn returned to consulting when she founded 1798, where her leadership has helped multiple companies achieve first-in-industry market access milestones. Prior, she was a managing director at The Aequitas Group and a global director of health economics at Johnson & Johnson. She earned a bachelor’s degree in international and public affairs at Princeton University and an MBA with a concentration in marketing and biotechnology at Northwestern University Kellogg School of Management.
Kurt Hartman
Senior Vice President
Prior to joining 1798, Kurt Hartman served as general counsel, chief compliance officer, corporate secretary, and senior vice president, market access at Optimer Pharmaceuticals. Previously, he was the executive director of value and access at Eisai, the director of patient reimbursement support and assistance at Roche Laboratories, an associate director in managed markets at Boehringer-Ingelheim, and a nephrology national account sales lead at Amgen. Kurt earned his JD at Pepperdine University School of Law and holds a bachelor’s in anthropology from the University of California, Los Angeles.
Bill Hershfield
Vice President
Bill Hershfield joined 1798 after spending 22 years at Novartis, Amgen, and Allergan in functions that ranged from selling pharmaceuticals to developing access strategies for biologics and devices. Most recently, he was the director of medical benefit marketing at Allergan. Previously, Bill worked at Amgen as a Medicare account specialist, a payor marketing manager with the Medicare team, and finally as the director of value access for the Aranesp oncology franchise. He earned a Bachelor of Science from Colorado State University and a certificate in executive development from the Kellogg School of Management at Northwestern University.
Christine List
Vice President
Christine List is an accomplished healthcare leader with more than 25 years of experience in overseeing successful sales, marketing, and access initiatives while expanding brand profitability. Prior to joining 1798, Christine held a number of positions, including vice president, pharmacy product development for Optum Health and senior director, healthcare systems marketing at Biogen. She began her career at Sanofi Aventis where she was a regional account manager and a director for payer customers. She also held leadership positions in field and hospital sales across several therapeutic areas. Christine received her Bachelor of Arts from the University of Connecticut and a certificate in executive development from Stanford University through the United Healthcare Executive Development Program.
Carlos Meier
Vice President
Carlos Meier is a project and financial management professional with 11 years of experience across multiple disciplines, including pharmaceuticals, medical devices, quality management systems, clinical research, and logistics. Prior to joining 1798 Consultants, Carlos founded and managed Ambos America, a consulting firm focused on medical device companies in Latin America. Before that, he led an international project to develop and introduce an innovative wireless fetal heart rate monitor in a resource-poor environment. Carlos earned a master’s in health economics at the University of California, San Diego and a Bachelor of Science in business from Iowa State University.
Rachael Asselin
Vice President
Rachael Asselin is a seasoned expert in the biotechnology and pharmaceutical industries. Over the past 15 years she has developed market access strategy and promotional materials for several products across various disease states, including multiple sclerosis, oncology, hemophilia, and ultrarare diseases. As the director of payer marketing at Biogen Inc., Rachael developed market access and reimbursement strategy for new and inline products for multiple sclerosis and hemophilia and led a team of market access and marketing experts. As a consultant, she supported product launches, payer value proposition development, and services transitions for Takeda Oncology, Alexion Pharmaceuticals Inc., and Progenics Pharmaceuticals. Rachael holds a master’s degree in public health with a specialty in epidemiology / biostatistics from Boston University and a bachelor’s degree in biology from Connecticut College.
Bonnie Morgan
Vice President
Bonnie Morgan brings more than 20 years of experience in all aspects of the biopharmaceutical business, including finance, production planning, government affairs, marketing, sales, and operations. She joined 1798 after spending more than two years at Spectrum Pharmaceuticals, most recently as a global brand lead. Bonnie also spent more than 20 years at Amgen supporting the oncology, neurology, and nephrology businesses and held roles across multiple functions and disciplines, including 10-plus years in US and global market access functions. Before that, she was the marketing director for oncology value access and reimbursement where she supported multiple products and product launches. Bonnie earned a Master of Business Administration from Pepperdine University and has a Bachelor of Science in industrial technology from California Polytechnic State University, San Luis Obispo.
Brett Olson
Vice President
Brett Olson brings 15 years of healthcare industry knowledge to the 1798 team, with expertise in developing complex reimbursement strategies and solutions designed to facilitate brand growth and patient adherence to therapy. Before joining 1798, Brett served in several sales roles, including director of business development, account director, and national account manager at TrialCard. Other previous positions include nearly eight years with AstraZeneca as a sales representative in both the primary care and specialty care CNS settings. Additionally, his background includes sales and marketing roles with the Beasley Broadcast Group, Sports America, and McDonald’s Corporation. Brett received his Bachelor of Science in business administration with a concentration in marketing from East Carolina University.
Matthew Dunphy
Vice President
Matthew Dunphy is a business professional with 18 years of experience in business operations, finance, corporate development, contracting, sales, and marketing. Prior to joining 1798, he was responsible for new account acquisition, marketing communications and strategy, public relations, and existing client management at The Aequitas Group. Before that, he cofounded Medical Tourism Solutions, a medical tourism intermediary offering affordable surgical care overseas. Leveraging this experience, Matthew provides a unique perspective on the development of the healthcare industry in the United States and competing global alternatives. He earned a bachelor’s degree in economics from Willamette University and an MBA from the University of California, San Diego, Rady School of Management.
CONTACT

Get in touch

Ready to learn more? Let’s chat.

All fields required.

Please complete the form.

Email is invalid.

Thanks!

We will be in touch shortly!

At Fingerpaint and any of our affiliate companies, we believe privacy is a fundamental human right. Read how we are dedicated to protecting that right in our complete Privacy Policy.